Search
Study of Pediatric Cancers Shows Strong Link Between Tumor Microdiversity and Prognosis
- OPACC
- Jan 27, 2015
- 1 min read
NEW YORK (GenomeWeb) – Measuring the microdiversity in the tumors of children treated with chemotherapy could help predict which kids are more likely to see their cancer progress and could potentially guide more personalized treatment strategies for at least some childhood cancers, new data has shown.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments